American Portfolios Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-295
Closed -$20K 2972
2019
Q3
$20K Hold
295
﹤0.01% 1659
2019
Q2
$17.2K Hold
295
﹤0.01% 1718
2019
Q1
$20.7K Hold
295
﹤0.01% 1574
2018
Q4
$19K Buy
295
+105
+55% +$7.36K ﹤0.01% 1393
2018
Q3
$13.3K Hold
190
﹤0.01% 1637
2018
Q2
$9.58K Hold
190
﹤0.01% 1731
2018
Q1
$5.95K Buy
+190
New +$6.3K ﹤0.01% 1823

American Portfolios Advisors's GHDX Position: Q4 2019 in Review

American Portfolios Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 295 shares — an estimated $20K sold.

American Portfolios Advisors first reported a position in GHDX in Q1 2018 and held it in 7 quarters. The position peaked at $20.7K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • American Portfolios Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 295 Genomic Health, Inc. shares in Q4 2019, an estimated $20K.
  • American Portfolios Advisors first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 7 quarters.
  • American Portfolios Advisors's Genomic Health, Inc. position peaked at $20.7K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.